Reinsurance (Tables)

9 Months Ended

Sep. 30, 2021

The effect of all of our reinsurance agreements on premiums earned and losses incurred is shown in table 4.1 below.


Reinsurance
Table	4.1
		Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)		2021		2020		2021		2020
Premiums earned:
Direct		$	287,223	$	300,557	$	876,541	$	896,346
Assumed		2,660		2,729		7,551		8,719
Ceded (1)		(35,039)		(47,173)		(122,664)		(144,489)
Net premiums earned		$	254,844	$	256,113	$	761,428	$	760,576

Losses incurred:
Direct		$	17,265	$	61,164	$	103,319	$	383,950
Assumed		(97)		229		(43)		528
Ceded		3,598		(20,707)		(13,710)		(65,462)
Losses incurred, net		$	20,766	$	40,686	$	89,566	$	319,016

(1) Ceded premiums earned net of profit commission

Schedule Of Quota Share Reinsurance Agreements

Table 4.2 below provides additional detail regarding our QSR Transactions.


Reinsurance
Table	4.2

Quota Share Contract		Covered Policy Years	Quota Share %		Annual Loss Ratio to Exhaust Profit Commission (1)		Contractual Termination Date
2015 QSR		Prior to 2017	15.0	%	68.0	%	December 31, 2031
2017 QSR		2017	30.0	%	60.0	%	December 31, 2028
2018 QSR		2018	30.0	%	62.0	%	December 31, 2029
2019 QSR		2019	30.0	%	62.0	%	December 31, 2030
2020 QSR		2020	12.5	%	62.0	%	December 31, 2031
2020 QSR and 2021 QSR		2020 - 2021	17.5	%	62.0	%	December 31, 2032
2021 QSR		2021	12.5	%	57.5	%	December 31, 2032
2022 QSR		2022	15.0	%	57.5	%	December 31, 2033
Credit Union QSR (2)		2020-2025	65.0	%	50.0	%	December 31, 2039

(1) We will receive a profit commission provided the annual loss ratio on policies covered under the transaction remains below this ratio.

(2) Eligible credit union business written before April 1, 2020 was covered by our 2019 and prior QSR Transactions.

Table 4.3 provides additional detail regarding optional termination dates and optional reductions to our quota share percentage which can, in each case, be elected by us for a fee. The optional reduction to the quota share percentage would give us an option to reduce our quota share percentage from the original percentage shown in table 4.2 to the percentage shown in table 4.3.

Reinsurance

Table

4.3

Quota Share Contract

Optional Termination Date (1)

Optional Quota Share % Reduction Date (2)

Quota Share % Reduction

2015 QSR

June 30, 2021

2017 QSR

December 31, 2021

2018 QSR

December 31, 2021

2019 QSR

December 31, 2021

July 1, 2020

25% or 20%

2020 QSR

December 31, 2022

July 1, 2021

10.5% or 8%

2020 QSR and 2021 QSR, 2020 Policy year

December 31, 2022

July 1, 2021

14.5% or 12%

2020 QSR and 2021 QSR, 2021 Policy year

December 31, 2023

July 1, 2022

14.5% or 12%

2021 QSR

December 31, 2023

July 1, 2022

10.5% or 8%

2022 QSR

December 31, 2024

July 1, 2023

12.5% or 10%

(1) We can elect early termination of the QSR Transaction beginning on this date, and bi-annually thereafter for the 2015 QSR, 2019 QSR, 2020 QSR, 2021 QSR, and 2022 QSR. Early termination of the 2018 QSR can be elected on this date and annually thereafter.

(2) We can elect to reduce the quota share percentage beginning on this date, and bi-annually thereafter.

Effect of quota share reinsurance agreements on premiums earned and losses incurred

Table 4.4 below provides a summary of our QSR Transactions, excluding captive agreements, for the three and nine months ended September 30, 2021 and 2020.


Quota Share Reinsurance
Table	4.4
		Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)		2021		2020		2021		2020
Ceded premiums written and earned, net of profit commission		$	22,911	$	43,448	$	90,284	$	131,651
Ceded losses incurred		(3,598)		20,707		13,710		65,493
Ceding commissions (1)		13,599		12,128		39,657		35,518
Profit commission		45,078		17,191		108,000		45,939

(1)Ceding commissions are reported within Other underwriting and operating expenses, net on the consolidated statements of operations.

Schedule of coverages and retention

Table 4.5 provides a summary of our Home Re Transactions as of September 30, 2021 and December 31, 2020.


Excess of Loss Reinsurance
Table 4.5
($ in thousands)	Home Re 2021-2, Ltd.	Home Re 2021-1, Ltd.	Home Re 2020-1, Ltd.	Home Re 2019-1, Ltd.	Home Re 2018-1, Ltd.
Issue Date	August 3, 2021	February 2, 2021	October 29, 2020	May 25, 2019	October 30, 2018
Policy Inforce Dates	January 1, 2021 - May 28, 2021	August 1, 2020 - December 31, 2020	January 1, 2020 - July 31, 2020	January 1, 2018 - March 31, 2019	July 1, 2016 - December 31, 2017
Optional Call Date (1)	July 25, 2028	January 25, 2028	October 25, 2027	May 25, 2026	October 25, 2025
Legal Maturity	12.5 years	12.5 years	10 years	10 years	10 years
Initial First Layer Retention	190,159	211,159	275,283	185,730	168,691
Initial Excess of Loss Reinsurance Coverage	398,429	398,848	412,917	315,739	318,636
September 30, 2021
Remaining First Layer Retention	190,159	211,159	275,268	184,007	165,434
Remaining Excess of Loss Reinsurance Coverage	398,429	398,848	288,777	208,146	218,343
December 31, 2020
Remaining First Layer Retention	—	—	275,283	184,514	166,005
Remaining Excess of Loss Reinsurance Coverage	—	—	412,917	208,146	218,343

(1)We have the right to terminate the Home Re Transactions under certain circumstances and on any payment date on or after the respective Optional Call Date.

Schedule of total assets of Home Re

Table 4.6 presents the total assets of the Home Re Entities as of September 30, 2021 and December 31, 2020.


Home Re total assets
Table	4.6
(In thousands)
Home Re Entity (Issue date)		Total VIE Assets
September 30, 2021
Home Re 2018-1 Ltd.		$	218,343
Home Re 2019-1 Ltd.		208,146
Home Re 2020-1 Ltd.		312,199
Home Re 2021-1 Ltd.		398,848
Home Re 2021-2 Ltd.		398,429

December 31, 2020
Home Re 2018-1 Ltd.		$	218,343
Home Re 2019-1 Ltd.		208,146
Home Re 2020-1 Ltd.		412,917

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details